Cargando…
Apoptosis, Autophagy, NETosis, Necroptosis, and Pyroptosis Mediated Programmed Cell Death as Targets for Innovative Therapy in Rheumatoid Arthritis
Rheumatoid arthritis (RA) is a chronic inflammatory joint disease that can lead to clinical manifestations of systemic diseases. Its leading features include chronic synovial inflammation and degeneration of the bones and joints. In the past decades, multiple susceptibilities for rheumatoid arthriti...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8739882/ https://www.ncbi.nlm.nih.gov/pubmed/35003139 http://dx.doi.org/10.3389/fimmu.2021.809806 |
_version_ | 1784629195537645568 |
---|---|
author | Zhao, Jianan Jiang, Ping Guo, Shicheng Schrodi, Steven J. He, Dongyi |
author_facet | Zhao, Jianan Jiang, Ping Guo, Shicheng Schrodi, Steven J. He, Dongyi |
author_sort | Zhao, Jianan |
collection | PubMed |
description | Rheumatoid arthritis (RA) is a chronic inflammatory joint disease that can lead to clinical manifestations of systemic diseases. Its leading features include chronic synovial inflammation and degeneration of the bones and joints. In the past decades, multiple susceptibilities for rheumatoid arthritis have been identified along with the development of a remarkable variety of drugs for its treatment; which include analgesics, glucocorticoids, nonsteroidal anti-inflammatory medications (NSAIDs), disease-modifying anti-rheumatic drugs (DMARDs), and biologic response modifiers (bDMARDs). Despite the existence of many clinical treatment options, the prognosis of some patients remains poor due to complex mechanism of the disease. Programmed cell death (PCD) has been extensively studied and ascertained to be one of the essential pathological mechanisms of RA. Its dysregulation in various associated cell types contributes to the development of RA. In this review, we summarize the role of apoptosis, cell death-associated neutrophil extracellular trap formation, necroptosis, pyroptosis, and autophagy in the pathophysiology of RA to provide a theoretical reference and insightful direction to the discovery and development of novel therapeutic targets for RA. |
format | Online Article Text |
id | pubmed-8739882 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-87398822022-01-08 Apoptosis, Autophagy, NETosis, Necroptosis, and Pyroptosis Mediated Programmed Cell Death as Targets for Innovative Therapy in Rheumatoid Arthritis Zhao, Jianan Jiang, Ping Guo, Shicheng Schrodi, Steven J. He, Dongyi Front Immunol Immunology Rheumatoid arthritis (RA) is a chronic inflammatory joint disease that can lead to clinical manifestations of systemic diseases. Its leading features include chronic synovial inflammation and degeneration of the bones and joints. In the past decades, multiple susceptibilities for rheumatoid arthritis have been identified along with the development of a remarkable variety of drugs for its treatment; which include analgesics, glucocorticoids, nonsteroidal anti-inflammatory medications (NSAIDs), disease-modifying anti-rheumatic drugs (DMARDs), and biologic response modifiers (bDMARDs). Despite the existence of many clinical treatment options, the prognosis of some patients remains poor due to complex mechanism of the disease. Programmed cell death (PCD) has been extensively studied and ascertained to be one of the essential pathological mechanisms of RA. Its dysregulation in various associated cell types contributes to the development of RA. In this review, we summarize the role of apoptosis, cell death-associated neutrophil extracellular trap formation, necroptosis, pyroptosis, and autophagy in the pathophysiology of RA to provide a theoretical reference and insightful direction to the discovery and development of novel therapeutic targets for RA. Frontiers Media S.A. 2021-12-24 /pmc/articles/PMC8739882/ /pubmed/35003139 http://dx.doi.org/10.3389/fimmu.2021.809806 Text en Copyright © 2021 Zhao, Jiang, Guo, Schrodi and He https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Immunology Zhao, Jianan Jiang, Ping Guo, Shicheng Schrodi, Steven J. He, Dongyi Apoptosis, Autophagy, NETosis, Necroptosis, and Pyroptosis Mediated Programmed Cell Death as Targets for Innovative Therapy in Rheumatoid Arthritis |
title | Apoptosis, Autophagy, NETosis, Necroptosis, and Pyroptosis Mediated Programmed Cell Death as Targets for Innovative Therapy in Rheumatoid Arthritis |
title_full | Apoptosis, Autophagy, NETosis, Necroptosis, and Pyroptosis Mediated Programmed Cell Death as Targets for Innovative Therapy in Rheumatoid Arthritis |
title_fullStr | Apoptosis, Autophagy, NETosis, Necroptosis, and Pyroptosis Mediated Programmed Cell Death as Targets for Innovative Therapy in Rheumatoid Arthritis |
title_full_unstemmed | Apoptosis, Autophagy, NETosis, Necroptosis, and Pyroptosis Mediated Programmed Cell Death as Targets for Innovative Therapy in Rheumatoid Arthritis |
title_short | Apoptosis, Autophagy, NETosis, Necroptosis, and Pyroptosis Mediated Programmed Cell Death as Targets for Innovative Therapy in Rheumatoid Arthritis |
title_sort | apoptosis, autophagy, netosis, necroptosis, and pyroptosis mediated programmed cell death as targets for innovative therapy in rheumatoid arthritis |
topic | Immunology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8739882/ https://www.ncbi.nlm.nih.gov/pubmed/35003139 http://dx.doi.org/10.3389/fimmu.2021.809806 |
work_keys_str_mv | AT zhaojianan apoptosisautophagynetosisnecroptosisandpyroptosismediatedprogrammedcelldeathastargetsforinnovativetherapyinrheumatoidarthritis AT jiangping apoptosisautophagynetosisnecroptosisandpyroptosismediatedprogrammedcelldeathastargetsforinnovativetherapyinrheumatoidarthritis AT guoshicheng apoptosisautophagynetosisnecroptosisandpyroptosismediatedprogrammedcelldeathastargetsforinnovativetherapyinrheumatoidarthritis AT schrodistevenj apoptosisautophagynetosisnecroptosisandpyroptosismediatedprogrammedcelldeathastargetsforinnovativetherapyinrheumatoidarthritis AT hedongyi apoptosisautophagynetosisnecroptosisandpyroptosismediatedprogrammedcelldeathastargetsforinnovativetherapyinrheumatoidarthritis |